Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/11061
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Carlberg, M | en |
dc.contributor.author | Jarrott, B | en |
dc.contributor.author | Beart, P M | en |
dc.date.accessioned | 2015-05-16T00:38:23Z | |
dc.date.available | 2015-05-16T00:38:23Z | |
dc.date.issued | 1991-01-14 | en |
dc.identifier.citation | Neuroscience Letters; 122(1): 29-32 | en |
dc.identifier.govdoc | 2057133 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | http://ahro.austin.org.au/austinjspui/handle/1/11061 | en |
dc.description.abstract | The 125I-labeled sulfonated cholecystokinin (CCK) analogue, D-Tyr25(Nle28,31)-CCK(25-33), bound saturably and reversibly to membranes of rat cerebral cortex. The dissociation constant Kd was estimated to be 0.14 nM by Scatchard analysis and 0.40 nM from analyses of dissociation/association rates. Hill coefficients of 0.99, Scatchard plots and drug competition studies were consistent with a single population of binding sites. Dependence on divalent cations and inhibition by guanylyl-imidodiphosphate suggested binding to a receptor coupled to a G protein. Competition studies with CCK-analogues and non-peptide specific antagonists indicated binding to receptor sites of the B-subtype (CCKB). | en |
dc.language.iso | en | en |
dc.subject.other | Animals | en |
dc.subject.other | Benzodiazepinones.metabolism | en |
dc.subject.other | Binding, Competitive | en |
dc.subject.other | Cerebral Cortex.metabolism | en |
dc.subject.other | Cholecystokinin.analogs & derivatives.metabolism | en |
dc.subject.other | Half-Life | en |
dc.subject.other | In Vitro Techniques | en |
dc.subject.other | Iodine Radioisotopes.diagnostic use | en |
dc.subject.other | Kinetics | en |
dc.subject.other | Male | en |
dc.subject.other | Membranes.metabolism | en |
dc.subject.other | Peptide Fragments.metabolism | en |
dc.subject.other | Phenylurea Compounds | en |
dc.subject.other | Rats | en |
dc.subject.other | Rats, Inbred Strains | en |
dc.subject.other | Receptors, Cholecystokinin.antagonists & inhibitors.metabolism | en |
dc.title | Specific binding of D-Tyr25 (Nle28,31)-CCK(25-33) to cortical membranes from rat brain. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | Neuroscience letters | en |
dc.identifier.affiliation | University of Melbourne, Clinical Pharmacology and Therapeutics Unit, Austin Hospital, Heidelberg, Vic. | en |
dc.description.pages | 29-32 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/2057133 | en |
dc.type.austin | Journal Article | en |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.openairetype | Journal Article | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.